Brought to you by 
Bio-Rad buys Pasteur Sanofi Diagnostics for $210mm
30 Aug 2004
Executive Summary
Bio-Rad Labs (manufactures/distributes life science research products, clinical diagnostics) has acquired Pasteur Sanofi Diagnostics, which is jointly owned by Sanofi-Synthelabo SA and the nonprofit Institut Pasteur. Bio-Rad gets 100% of PSD shares as well as certain assets for $210mm, and will assume some debt.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Cytology
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Bio-Rad buys Pasteur Sanofi Diagnostics for $210mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice